Delivery Order SPE2DB22D1106-SPE2DB24FFFN6
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,879.52 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,776.36 firm-fixed-price contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $1,051.65 and a completion date of May 21, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,627.35 firm fixed-price contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of August 10, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $6,599.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for Gralise ER 300 mg tablets and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
This is a $14,845.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The delivery order has a completion date of January 12, 2024 and was awarded on January 11, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $13,072.71 and is a firm fixed price contract with a completion date of June 23, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,441.79, is for the delivery of Gralise ER 300 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription drug product, with a total ceiling value of $4,162.48. The contract has a firm fixed price pricing type and is set to expire on September 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen, through its Corporate...